<DOC>
	<DOCNO>NCT01195532</DOCNO>
	<brief_summary>The 2 × 2 crossover design study evaluate bioequivalence two different MR tablet gliclazide single oral administration dose healthy subject .</brief_summary>
	<brief_title>An Open-randomized , Balanced , Crossover Bioequivalence Study Compare One MR Tablet 60 mg Gliclazide Two MR Tablets 30 mg Gliclazide Healthy Subjects</brief_title>
	<detailed_description>The 2 × 2 crossover design study evaluate bioequivalence two different MR tablet gliclazide single oral administration dose healthy subject .</detailed_description>
	<mesh_term>Hyperglycemia</mesh_term>
	<mesh_term>Gliclazide</mesh_term>
	<criteria>Subjects enrol study accord follow criterion : 1 . Subjects must male age 2040 year old good health basis medical history , physical examination , electrocardiogram , chest Xray , routine laboratory evaluation . 2 . Vital sign ( 3 minute rest upright position ) within follow range : Ear body temperature 35.037.5 °C . Systolic blood pressure , 90140 mm Hg . Diastolic blood pressure , 5090 mm Hg . Pulse rate , 5090 bpm . Fasting blood glucose , &lt; 100 mg/dL . 3 . Body weight must great 50 kg within 20 +20 % ideal body weight . 4 . Able sign inform consent prior study . 5 . Able communicate well investigator comply requirement study . Subjects meet follow criterion prestudy examination evaluation exclude entry continuation study : 1 . Use prescription medication within 14 day prior dose . 2 . Use overthecounter medication vitamin within 14 day prior dose . 3 . Significant illness within 2 week prior dose . 4 . Participation clinical investigation within 2 month prior dose longer required local regulation . 5 . Donate loss 500 mL blood within 3 month prior dose . 6 . Presence cardiovascular disease . 7 . Presence gastrointestinal disease . 8 . Presence asthma lung disease . 9 . Presence liver disease , hepatitis B , hepatitis C liver injury indicate abnormal liver function profile GOT , GPT , gamaGT , alkaline phosphatase , serum bilirubin , HBsAg , AntiHCV . 10 . Presence impair renal function indicate abnormal creatinine BUN value abnormal urinary constituent ( e.g. , albuminuria ) . 11 . Presence neurological disease . 12 . Presence psychiatrical disease . 13 . Subject know HIV infect . 14 . A known hypersensitivity gliclazide analog . 15 . History drug alcohol abuse within 12 month prior dose . 16 . Permanent confinement institution . 17 . Individuals judge investigator pharmacokineticist undesirable subject reason .</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>hypoglycemic drug</keyword>
</DOC>